Business Context and Reporting Period
Instil Bio, Inc. (TIL), an emerging growth company, filed this Form 8-K on December 20, 2024. The report details a material definitive agreement entered into by Complex Therapeutics LLC, a wholly-owned subsidiary, to refinance debt secured by its facility in Tarzana, California.
Key Financial Metrics
- New Debt Principal: $85.6 million term loan.
- Interest Rate: Fixed at 6.35% per annum.
- Loan Term: Two years with a one-year extension option.
- Payment Structure: Interest-only payments during the term; principal due in full at maturity.
- Prepayment Terms: Prepayment allowed in whole but not in part. A fee applies if prepaid within the first 12 months to make the lender whole; no fee applies after 12 months.
- Collateral: First mortgage lien on the Tarzana property, assignment of leases/rents, and a first priority security interest in all other assets of the Borrower.
- Recourse Status: Generally non-recourse, subject to a Recourse Indemnity Agreement for specific carveouts (e.g., bankruptcy, insolvency, violation of debt covenants, or unauthorized transfer of property).
Material Changes Versus Prior Period
The Company terminated its previous Construction Loan Agreements and related Mezzanine Loan Agreement with OP USA Debt Holdings II Limited Partnership (successor to OPG Hermes Investments). The proceeds from the new $85.6 million loan were used to repay these prior construction and development loans in full.
Guidance, Covenants, and Risks
- Financial Covenants: The Company must maintain a consolidated net worth of at least $50 million (excluding interest in the Property) and minimum liquidity of $17.1 million.
- Extension Conditions: The one-year extension option requires no defaults, payment of a 0.35% extension fee, replenishment of reserve funds, and compliance with minimum debt yield and debt service coverage ratios.
- Risks: The loan includes customary events of default and cash sweep provisions. Full recourse to the Company is triggered by voluntary bankruptcy, substantive consolidation, or specific covenant breaches.
Investor Verification Checklist
- Verify the Company's current consolidated net worth and liquidity levels against the $50 million and $17.1 million covenants.
- Confirm the status of the Tarzana, California facility and its lease/rental income to ensure debt service coverage requirements are met.
- Review the full text of the 2024 Loan Agreement and Recourse Indemnity Agreement (to be filed as exhibits to the 2024 Form 10-K) for detailed default triggers.
- Monitor the Company's ability to meet the 0.35% extension fee and reserve fund requirements if the one-year extension is pursued.